• The objectives of WP7-A were to determine the types of structured collaboration that would facilitate evidence generation and to create a web-based toolkit that would support this collaboration. This document presents the result in the form of a web-based toolkit.

  • The final version of the WP5 JA1 pilot assessment using the draft model for Rapid Relative Effectiveness Assessment of Pharmaceuticals and guidelines.

    The joint assessment involved the participation of 22 HTA organisations as authors on different domains or as reviewers. Find the full list on page 16 in side the report.

  • It is the remit of WP5 to develop tools for relative effectiveness assessment of pharmaceuticals. This document briefly presents the products of WP5 from EUnetHTA Joint Action 1.

  • This document describes processes planned for conducting pilot rapid assessments for pharmaceuticals. Since the Procedure Manual is a living document, further changes can be expected due to experiences gathered throughout JA2.

  • This document describes processes planned for conducting pilot rapid assessments for other technologies such as medical devices, surgical interventions or diagnostics. Since the Procedure Manual is a living document, further changes can be expected due to experiences gathered throughout JA2.